The Division of Surgical Sciences is organized around a matrix structure that encourages scientific interactions among the individual programs as a means of optimizing research synergy and productivity. 

 

The programs include:

Cardiovascular Biology - the Cardiovascular Biology Program is focused on multidisciplinary translational research approaches to the study of blood coagulation, inflammation, and atherogenesis at the molecular level.  Novel anti-coagulation approaches developed within the program are presently undergoing pre-clinical and clinical evaluation.  Ongoing studies are aimed at exploring molecular therapeutic approaches in the treatment of cardiovascular disease.

Cancer - the Cancer Program encompasses the broad interests of several key division faculty members whose research interest, including cancer genetics, cancer biology, and the development of novel vaccine/therapeutic strategies.

Vaccines - investigators in the Vaccines Program explore a broad range of multidisciplinary approaches to development and testing in the arena of therapeutic strategies for various human cancers and infectious diseases.

Molecular/Nano Therapeutics - the Molecular/Nano Therapeutics Program applies state-of-the-art molecular and nanotechnologies to the development of novel therapeutic strategies for cancer as well as autoimmune and infectious diseases.

Immunology - the Immunology Program is centered on dendritic cell antigen presentation platforms and an extensive repertoire of immune monitoring technologies to support the development and clinical testing of novel immune-based therapies.

Transplantation - faculty members in the Transplantation Program conduct basic and clinical research studies aimed to better understand barriers of solid organ transplantation in order to improve on the clinical outcomes of this vital surgical intervention.  The program has particular interest in the broad scientific issues surrounding abdominal organ transplants.